In order to investigate the selective breakdown of the blood-retinal barrier in pos terior uveitis angiograms were performed using fluorescein-conjugated dextrans (FITC-dextrans) of different molecular weights Leakage of sodium fluorescein from inflamed retinal vessels is a characteristic angiographic feature of posterior uveitis and results from breakdown of the blood-retinal barrier (BRB) at sites such as the optic disc, macula, and areas of neovascularization.1 However, standard fluorescein angiography gives qual itative rather than quantitative information, and, because fluorescein is a small molecule (376-0a), will not differentiate between degrees of BRB breakdown that might allow molecules of different molecular weight access to the retina. Prompted by the finding that 50% of our retinal vasculitis patients have circulating antibodies to retinal proteins," which might be pathogenic if able to enter the retina, we set out to measure the size of molecules able to leak from the retinal vessels of such patients.
Leakage of sodium fluorescein from inflamed retinal vessels is a characteristic angiographic feature of posterior uveitis and results from breakdown of the blood-retinal barrier (BRB) at sites such as the optic disc, macula, and areas of neovascularization.1 However, standard fluorescein angiography gives qual itative rather than quantitative information, and, because fluorescein is a small molecule (376-0a), will not differentiate between degrees of BRB breakdown that might allow molecules of different molecular weight access to the retina. Prompted by the finding that 50% of our retinal vasculitis patients have circulating antibodies to retinal proteins," which might be pathogenic if able to enter the retina, we set out to measure the size of molecules able to leak from the retinal vessels of such patients.
The glucose polymer dextran, available in a wide range of defined molecular weights, can be conjugated at multiple sites with fluores cein isothiocyanate (FlTC) to produce high molecular weight fluorescent molecules which can be used as tracers in vascular permeability studies. 3.� Studies using these markers have quantified vascular leakage of the BRB in rats with urethane induced retinopathy, ' and pri· mates with experimental posterior uveitis. 6 We report here for the first time in man a method of using graded FITC-dextrans, after the appropriate toxicological studies, in assessing retinal vascular damage in patients with posterior uveitis.
Methods

Manufacture of FITC-dextrans for injection
FITC-dextrans of molecular weights 4-kDa, 20-kDa and lS0-kDa (FD-4, FD-20, and FD-1S0 respectively) were purchased from Sigma Chemical Company Ltd (Poole, Dorset, UK) and dissolved in sterile normal saline at 10% w/v. The resulting solutions were sterilized by filtration through 0.2 !-lm fil ters (Amicon Ltd, Gloucester, UK) before being packaged into sterile glass ampoules and stored at 4°C. The raw materials were assayed for solubility, chromatographic purity and heavy metal contamination. The finished product� had a ptl6.5, were a55ayed by ultraviolet spectroscopy, and investigated for the presence of foreign protein, 7 endotoxin (Wickham Laboratories Ltd, Fareham, UK), and sterility (British Pharmacopoeia, 1988) . Their acute toxicity to rats (Huntingdon Research Centre, Huntingdon. UK) and chemical stability in solution by chromato graphic anlaysis was also determined.
Patient selection
All experiments were performed with the ap proval of the West Lambeth Health Auth ority Ethical Committee and patients gave informed consent to the procedure. Two normal subjects (EGA and SJ) and. six patients with posterior uveitis were selected for study (Table I ). The patients were chosen for their representative features of active pos terior uveitis. No patient had ever suffered an allergic reaction.
Angiographic procedure
A Zeiss fundus camera with conventional flu orescein filters and maximum flash setting was �sed for photography. Colour fundus photo graphs were recorded on Ectachrome 64 film �ymptom�, blood prc�mrc. and pulJC wcre made at intervals throughout the procedure. Sequential blood and urine samples were taken to measure FITC-dextran concentra tion, and for tests of hepatic and renal function.
Results
Analysis of raw material and finished products
All FITC-dextrans were easily dissolved in saline. The raw materials were found to con tain less than IS ppm w/w of each of the heavy metals Cd, Hg, Sn, As, Pb and Sb by induc tively coupled plasma Atomic Emission Spec troscopy (British Pharmacopoeia limit 20 ppm), and were found to have a single mol ecular weight peak on gel filtration. Each fin ished product was found to contain less than 1.0 EU/ml of endotoxin (limit S.O EU/ml), no foreign protein and to be sterile. No product was significantly toxic to rats when admin istered at 18 times the proposed human dose and each was stable in solution for at least a year, showing no evidence of degradation into smaller molecular weight species.
Subject responses to injection
No subject experienced any symptoms after injection of any of the FITC-dextrans. There were no significant changes in pulse rate or blood pressure and no changes in haemat ological indices. or renal or hepatic function. No injection caused significant visible skin staining. The FITC-dextrans disappeared from the circulation with a half-life propor tional to their molecular weight, with FDA and FD-20 being excreted unchanged into the urine.
FITC-dextran angiography in normal subjects
Angiograms recorded following injection of FD-4, FD-20 and FD-1S0 in the two normal subjects demonstrated good vascular detail during the arterio-venous (A-V) phase, which was still leasily visible at 10 minutes after injection (Fig. 1) . FD-20 gave angiograms of greatest intensity and FD-1S0 of least, in par allel with the estimated amount of fluorescein administered (Table II) . At ten minutes the dye was still present in the vasculature in all three angiograms but details of both disc and macula were only visible with FD-20. Flu orescent staining of the optic disc did not pro gress beyond the A-V phase and the macula remained dark throughout. Because the amount of fluorescein administered was small (Table II) the intensity of fluorescence observed by the photographer was low during the A-V phase and barely discernible during the late venous phase. The grain evident on the angiograms resulted from the nature of the film/developer combination used and gave a rather low contrast picture.
FITC-dextran angiography in retinal vasculitis patients
Overall, the angiographic detail in posterior uveitis patients was less than in normal sub jects because of media opacities, in particular vitreous haze. However, sufficient detail was preserved to allow reliable determination of leakage using the processed films. Leakage of FITC-dextrans was assessed at the optic disc, macula and areas of neovascularization.
Optic disc: The optic disc leaked NaFi in four 'Present as the disodium salt 2Amount present in 10 m[ of a 10';10 w/v solution 3Effective diffusion radius (EDR) estimated in nm of six patients examined. At ten minutes FD-4 was clearly observed to leak from the optic disc and peripapillary region in three patients (Fig. 2) . At this time FD-20 leakage was less obvious but discernible particularly at the inferior pole of the disc in these patients whereas FD-1SO leaked from the optic disc of only two patients and was barely visible at ten minutes. Leakage of FITC-dextrans never extended beyond the boundaries of NaFI leakage.
Macula: Whereas NaFI leaked from most areas of the macula in five of the patients stud ied, the FITC-dextrans leaked in a more selective manner from within the areas of NaFl leakage (Fig. 3) . Both FD-4 and FD-20 leaked in four patients whereas only FD-20 leaked in another, perhaps reflecting its greater fluorescent intensity, although at ten minutes FD-4 was seen more easily than FD-20 which was barely discernible. FD-1SO did not leak into any of the maculas studied.
New vessels: FD-4 leaked from retinal new vessels but much more slowly than NaFl (Fig. 4) . Other de2(trans showed no leakage.
Discussion
This study has demonstrated that FITC-dex- tran angiography in man is a safe and feasible technique. The angiograms obtained were of sufficient quality to be used to determine the molecular size of leakage from diseased ret inal vessels at various sites in eyes with pos terior uveitis. FITC-dextrans are chemical conjugates of fluorescein and dextran, both of which are widely used in medicine with an acceptable incidence of adverse effects. Thus it is not surprising that, given the stringent quality control of the finished product under taken in this study, there should have been no systemic toxIcity observed after intravenous injection of any of the FITC-dextrans. Although under experimental conditions some FITC-dextrans may enhance leucocyte endothelial adhesion/ there was no evidence of induction or progression of retinal inflam mation in any of the subjects studied. These compounds have previously been shown to be stable in aqueous solution,9 in plasma and in vivo"l and the retinal vascular leakage observed in this study can therefore be con fidently assigned molecular size values corre-sponding to the molecular weights of the substances injected (see Table II ). We observed FITC-dextrans of up to 150-kDa leaking from inflamed optic discs and of up to 20-kDa into areas of macular oedema, whereas only sodium fluorescein and 4-kDa leaked from areas of retinal neovascularisa tion. Due to the spectrum of disease in the patients selected for this study we were unable to give reliable estimates of leakage from areas of perivasculitis. Thus the molecular size of leakage from the optic disc in our patients (150-kDa: EDR 8. 5 nm) corresponds to the size of an immunoglobulin G molecule (160-kDa) whereas that seen at the macula (20-kDa: EDR 3. 2 nm) corresponds more closely to the size of �2-microglobulin (ca 20-kDa). However, size of leakage from retinal new vessels (4-kDa: EDR 1.3 nm) is so small that only small molecules are likely to be able to penetrate the perivascular space in such areas.
Using S-antigen-induced EAU in the rat as a model of human uveitis, II we have also found FITC-dextrans of up to 20-kDa to leak from areas of perivasculitis and optic disc swelling (unpublished data). Comparable findings have been described in IRBP induced experimental autoimmune uveo retinitis (EAU) in primates,� where the optic disc was shown to leak 150-kDa FITC-dextran and peripheral retinal vessels 70-kDa mol ecules. Similarly, FITC-dextrans of 3-kDa and 20-kDa have been shown to leak from ret inal vessels of rats with urethane or photo toxic retinopathy, I I and 40-kDa FITC dextrans did not leak.
Several explanations might be professed to interpret the cellular pathology of FITC-dex tran leakage at sites such as the optic disc and macular in posterior uveitis. Tight retinal endothelial junctions�12 might be severely dis- 6 were able to show in their primate model that leakage of large molecules (FD-150) was associated with breakdown of tight junctions between retinal endothelial cells. Areas that leaked smaller molecules (FD-70 or NaFI) showed no mor phological changes in junctions and they con cluded that the enhanced vascular permeability to smaller molecules was due to an increase in transcellular transport. Since our work broadly concurs with theirs it seems reasonable to suggest that similar mechanisms are operating in man.
A hypothesis might therefore be construc ted to explain this differential breakdown in the BRB based on the physiological ability of the retinal vascular endothelial cell to exclude large molecular weight proteins. Both NaFl and FDA were observed to leak from areas of neovascularisation. These new vessels are fenestrated but may have relatively normal endothelial cells lining them. Thus they may be able to exclude larger proteins (FD-20 and FD-lS0) whilst the smaller ones can escape either by enhanced transcellular transport or by passive diffusion across fenestrae. A similar situation is envisaged in macular oedema but the exclusion mechanisms of the endothelial cells are further compromised so that molecules of up to 20-kDa can get across. Finally, at the optic disc which leaked dex trans of all molecular weights, there may be a breakdown of the interendothelial junctions as well as compromised endothelial function. It is known that these chan g es are reversible as shown by the change in standard fluores cein patterns during treatment of posterior uveitis but whether the differential pattern of leaka g e in macula oedema for instance has prognostic value awaits to be determined.
In conclusion, differential retinal leakage of graded FITC-dextrans in uveitis patients appears to give a useful estimate of the size of plasma protein able to leak at sites of retinal inflammation. The technique might also be reasonably expected to measure the func tional state of the retinal endothelium in such eyes, and therefore FITC-dextran angiogra phy might usefully provide an objective measure of disease activity and subsequent prognosis in such patients.
